Emma Andrus, Editor

Catch up on coverage from the second day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

Subcutaneous spesolimab maintained durable GPP control for 12 months after rapid clearance from IV spesolimab in a high-risk elderly patient.

Adam Friedman, MD, FAAD, outlines a stepwise approach to treating chronic hand eczema, from vehicle selection to systemic therapies and future innovations.

Orit Markowitz, MD, shares how her color wheel method boosts diagnostic clarity in dermoscopy by simplifying how clinicians assess benign lesions.

A poster at SDPA highlights that dermatologists play a vital role in early detection of metastatic breast cancer, with skin changes often serving as the initial clue of internal disease recurrence.

Adam Friedman, MD, FAAD, breaks down how to differentiate chronic hand eczema from similar conditions using history, morphology, and key clinical clues.

Apremilast improved joint symptoms and quality of life in patients with early oligoarticular PsA, with consistent efficacy across all BMI categories.

Janelle Ball of BC Educators offers actionable tips to boost prior authorization success and improve patient support in dermatology practices.

Catch up on coverage from the first day of the 2025 SDPA Annual Summer Dermatology Conference held in Washington, DC.

A poster at SDPA 2025 highlights the importance of early biopsy and genetic testing in aggressive cSCC, even in young patients without classic risk factors.

DFD-29 showed strong efficacy in rosacea regardless of body weight in 2 phase 3 trials, outperforming both placebo and doxycycline.

Eileen Cheever, MPAS, PA-C, previews the SDPA Summer Dermatology Conference, calling it a can't-miss opportunity to learn, network, and reconnect.

Click here to answer our poll and let us know what you're looking forward to at the SDPA's summer conference.

Join Dermatology Times at SDPA 2025 as our expert board members take the stage to share clinical insights, pearls, and practice-changing perspectives.

The conference aimed at providing dermatology physician assistants with the latest in the specialty begins today in Washington, DC.

Dermatology Times is recapping our exclusive expert interviews from the month of June.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

UC Berkeley’s Broc Vargo shares how growing up in tanning salons inspired his passion for dermatology, sun safety, and public health advocacy.

Explore the top headlines of the week including insights on the latest clinical trials, therapeutic updates, and more.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Dupilumab gains FDA approval as the first targeted therapy for bullous pemphigoid, offering hope for effective treatment and improved patient outcomes.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This review of the latest dermatologic studies includes insights into differences in vitamin D levels in rosacea versus healthy individuals, psychosocial determinants and atopic dermatitis outcomes, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

At SCALE 2025, Christina Feser, DO, FAAD, FAOCD, spotlighted the rapidly expanding pipeline of diverse therapies for patients with HS.